INH14 is primarily used as a research compound in biochemical and pharmacological studies, particularly in the investigation of enzyme inhibition pathways. It has shown potential as a selective inhibitor in signaling pathways related to inflammatory responses, making it a candidate for studying autoimmune diseases and cancer progression. Due to its ability to modulate specific intracellular targets, INH14 is utilized in cell-based assays to probe kinase activity and assess therapeutic strategies for targeted therapy development. Its application extends to preclinical studies where it helps validate drug targets and optimize inhibitor design for improved efficacy and selectivity.